Managing Joint Pain in Perimenopausal Women on Hormone Replacement Therapy

Introduction to Hormone Replacement Therapy and Joint Pain

The American College of Cardiology recommends that perimenopausal women on hormone replacement therapy (HRT) should focus on standard musculoskeletal pain management while continuing HRT at the lowest effective dose, as the current hormone regimen is likely alleviating joint pain, not causing it 1

The appropriate dose for endometrial protection when used with estrogen in women with an intact uterus is 200 mg micronized progesterone at bedtime, according to the American College of Obstetricians and Gynecologists 1
Micronized progesterone is preferred over medroxyprogesterone acetate due to lower rates of venous thromboembolism and breast cancer risk, as recommended by the North American Menopause Society 1, 3

Transdermal estradiol patches releasing 50 μg daily should be the first-line choice, changed twice weekly, due to lower rates of venous thromboembolism and stroke compared to oral formulations, as suggested by the Endocrine Society 1

At 48 years old and perimenopausal, the patient falls within the optimal window for HRT (under 60 or within 10 years of menopause onset) where the benefit-risk profile is most favorable, according to the American College of Cardiology 1

The American Heart Association recommends using a stepped-care approach for musculoskeletal pain, starting with acetaminophen at appropriate doses for pain relief, then adding physical activity and/or acupuncture if insufficient, and considering referral for physical therapy or rehabilitation 4, 5
Nonselective NSAIDs (such as naproxen) may be used at the lowest effective dose for the shortest possible time if initial therapy fails, as recommended by the American College of Cardiology 4

The American College of Cardiology recommends reassessing pain severity at each clinical encounter using a standardized pain scale, continuing HRT at the lowest effective dose for symptom management, and planning for annual reassessment of HRT necessity 1, 2
Ensuring adequate calcium (1000 mg/day) and vitamin D (800-1000 IU/day) intake for bone health is also recommended by the National Osteoporosis Foundation 1